Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients

被引:77
|
作者
Battaini, F [1 ]
Pascale, A
Lucchi, L
Pasinetti, GM
Govoni, S
机构
[1] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy
[2] Univ Milan, Inst Pharmacol Sci, I-20133 Milan, Italy
[3] Fishberg Res Ctr Neurobiol, Dept Psychiat, Neuroinflammat Res Ctr, New York, NY USA
[4] Mt Sinai Sch Med, Brookdale Ctr Mol Biol, New York, NY USA
[5] Univ Pavia, Inst Pharmacol, Pavia, Italy
[6] IRCCS, Ctr S Giovanni Dio, FBF, Brescia, Italy
关键词
Alzheimer's disease; anchoring proteins; brain cortex; PKC activation; PKC beta II; RACK1;
D O I
10.1006/exnr.1999.7151
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Protein kinase C (PKC) has been implicated in the pathophysiology of Alzheimer's disease (AD). The levels of particular isoforms and the activation of PKC are reduced in postmortem brain cortex of AD subjects. Receptors for activated C kinase (RACK) are a family of proteins involved in anchoring activated PKCs to relevant subcellular compartments. Recent evidence has indicated that the impaired activation (translocation) of PKC in the aging brain is associated with a deficit in RACK1, the most well-characterized member of this family. The present study was conducted to determine whether alterations in RACK1 occurred in cortical areas where an impaired translocation of PKC has been demonstrated in AD. Here we report the presence of RACK1 immunoreactivity in human brain frontal cortex for the first time and demonstrate a decrease in RACK1 content in cytosol and membrane extracts in AD when compared with non-AD controls. By comparison, the levels of the RACK1-related PKC beta II were not modified in the same membrane extracts. These observations add a new perspective in understanding the disease-associated defective PKC signal transduction and indicate that a decrease in an anchoring protein for PKC is an additional determinant of this deficit. (C) 1999 Academic Press.
引用
收藏
页码:559 / 564
页数:6
相关论文
共 50 条
  • [21] Glutaminase in the cerebellum of patients with Alzheimer's disease: a postmortem brain study
    Burbaeva, G. Sh
    Boksha, I. S.
    Tereshkina, E. B.
    Starodubtseva, L. I.
    Savushkina, O. K.
    Vorobyeva, E. A.
    Prokhorova, T. A.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (12) : 71 - 75
  • [22] Quantification of hemorphins in Alzheimer's disease brains
    Poliak, A
    McLean, CA
    Sachdev, P
    Brodaty, H
    Smythe, GA
    JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 75 (05) : 704 - 714
  • [23] Reduced neuronal nitric oxide synthetase and C protein kinase levels in Alzheimer's disease
    Gargiulo, L
    Bermejo, M
    Liras, A
    REVISTA DE NEUROLOGIA, 2000, 30 (04) : 301 - 303
  • [24] Amyloid-β Protein Precursor Cleavage Products in Postmortem Ventricular Cerebrospinal Fluid of Alzheimer's Disease Patients
    Hartl, Daniela
    Gu, Wei
    Mayhaus, Manuel
    Pichler, Sabrina
    Schoepe, Jakob
    Wagenpfeild, Stefan
    Riemenschneider, Matthias
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (02) : 365 - 372
  • [25] Exploring phytochemical inhibitors of protein kinase C alpha for therapeutic targeting of Alzheimer's disease
    Aazad, A. A.
    Choudhury, Arunabh
    Hussain, Afzal
    Alajmi, Mohamed F.
    Mohammad, Taj
    Prabha, Sneh
    Sharma, Manoj Kumar
    Shamsi, Anas
    Hassan, Md Imtaiyaz
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 102 (03) : 703 - 719
  • [26] Reexamining the Causes and Effects of Cholesterol Deposition in the Brains of Patients with Alzheimer’s Disease
    Ze-Lin Hu
    Yang-Qi Yuan
    Zhen Tong
    Mei-Qing Liao
    Shun-Ling Yuan
    Ye Jian
    Jia-Lun Yang
    Wen-Feng Liu
    Molecular Neurobiology, 2023, 60 : 6852 - 6868
  • [27] Bleomycin hydrolase immunoreactivity in senile plaque in the brains of patients with Alzheimer's disease
    Namba, Y
    Ouchi, Y
    Takeda, A
    Ueki, A
    Ikeda, K
    BRAIN RESEARCH, 1999, 830 (01) : 200 - 202
  • [28] COX-2 expression in brains of patients with familial Alzheimer's disease
    Nogawa, S
    Takao, M
    Suzuki, S
    Tanaka, K
    Fukuuchi, Y
    Hayakawa, I
    Koto, A
    MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA, 2003, 1252 : 363 - 372
  • [29] Changes of activity and isozyme pattern of phosphofructokinase in the brains of patients with Alzheimer's disease
    Bigl, M
    Bleyl, AD
    Zedlick, D
    Arendt, T
    Bigl, V
    Eschrich, K
    JOURNAL OF NEUROCHEMISTRY, 1996, 67 (03) : 1164 - 1171
  • [30] Aberrant neuronal and paracellular deposition of endostatin in brains of patients with Alzheimer's disease
    Deininger, MH
    Fimmen, BA
    Thal, DR
    Schluesener, HJ
    Meyermann, R
    JOURNAL OF NEUROSCIENCE, 2002, 22 (24) : 10621 - 10626